期刊文献+

重组酵母产人IFN-α2a与LL-37融合蛋白的工艺优化

The Process Optimization of Pichia pastoris GS115LI for Producing Fused Protein of LL-37 and IFN-α2a
下载PDF
导出
摘要 通过单因素试验探索重组酵母P.pastoris GS115LI产人LL-37基因与IFN-α2a融合蛋白的最佳条件。结果显示,重组酵母菌产蛋白酶的最佳表达条件是利用BMMY为诱导培养基,以接种量OD600=5.5、温度26℃、p H6.0、诱导剂(甲醇)为每隔24 h添加1.0%、振荡速度为200 r/min条件下连续诱导144 h。在最佳培养条件下,发酵液中的LL-37最高抗菌活性达27.9 mm。与初始的发酵条件相比,人LL-37基因与IFN-α2a融合蛋白的产量提高了32.29%。 With experiments of single factor, the optimal process of recombinantP. pastoris GS115LI for producing fused protein of LL-37 and IFN-α2a were using BMMY as inducing medium, inoculum as OD600=5.5, temperature as 26℃, pH6.0, inducing chemical(methanol) adding amount as 1.0% every 24 h, incubating shaking speed as 200 r/min, and inducing time as 144 h. Under those optimal conditions, the 27.9 mm of LL-37 antimicrobial activity could be gotten. Compared with the original conditions, the productivity of fused protein of LL-37 and IFN-α2a was increased as 32.29%.
作者 张明杰
出处 《生物技术通报》 CAS CSCD 北大核心 2014年第11期214-218,共5页 Biotechnology Bulletin
基金 广东省重大科技专项(2011A080502011)
关键词 干扰素Α2A LL-37工艺 Interferon-α2a LL-37 Fermentation process
  • 相关文献

参考文献3

二级参考文献31

  • 1肖怀秋,林亲录,李玉珍,赵谋明.中性蛋白酶芽孢杆菌BX-4产酶条件及部分酶学性质[J].食品与生物技术学报,2005,24(4):42-46. 被引量:29
  • 2张富新,张媛媛,党亚丽,于月英.海藻酸钠固定化中性蛋白酶的研究[J].西北农林科技大学学报(自然科学版),2005,33(11):89-93. 被引量:14
  • 3高等学校轻工专业试用教材.工业发酵分析[M].北京:轻工业出版社,1986:90-92.
  • 4奥斯伯F 布伦特R 金斯顿RE 等 颜子颖 王海林 编译.精编分子生物学实验指南[M].北京:科学出版社,1998.366-373.
  • 5Lehrer RI, Ganz T. Cathelicidins: a family of endogenous antimicrobial peptides [ J ]. Curr Opin Hemato1,2002 ,9 ( 1 ) : 18 - 22.
  • 6Gudmundsson GH, Agerberth B, Adeberg J, et al. The humangene FALL - 39 and processing of the cathlin precursor to the antimicrobial peptide LL - 37 in granulocytes [ J ]. Eur J biochem,1996, 238(2) : 325 -332.
  • 7Gudmundsson GH, Magnusson KP, Chowdhary BP, et al. Structure of the gene for porcine peptide antibiotic PR -39, a cathelin gene family member: comparative mapping of the locus for the human peptide antibiotic FALL - 39 [ J ]. Proc Natl Acad SciUSA, 1995, 92:7085-7089.
  • 8Yang YX, Feng Yun, Wang BY, et al. PCR - based site - specific mutagensis of FALL -39 and its biologic activities[J]. Acta Pharmacological Sinica, 2004, 25(2) : 239 -245.
  • 9Oren Z, Lerman JC, Gudmundsson GH, et al. Structure and organization of the human antimicrobial peptide LL37 in phospholipid membranes: relevance to the molecular basis for its noncell- selective activity[J]. Biochem J, 1999, 341:501 -513.
  • 10Mark AF, Marek AK. A novel peptide - IgG conjugate, CAP18 106 - 138 - IgG, that binding and neutralizes endotoxin and kills Gram- negative bacteria[J]. Infectious Disease, 1997, 175:621.

共引文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部